Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.
Journal: Seminars in hematology
Published: May 11, 2026
Mutation-specific impairment of TET2 and DNMT3A enzymatic activity predicts clonal hematopoiesis disease risk.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
Journal: American journal of hematology
Published: January 05, 2026
Pacritinib in patients with myelodysplastic/myeloproliferative neoplasms.
Journal: Leukemia & lymphoma
Published: November 26, 2025
Leukemia cutis and all-trans retinoic acid-induced myocarditis in acute promyelocytic leukemia.
Journal: Clinical hematology international
Published: November 11, 2025
Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experience.
Journal: Frontiers in immunology
Published: October 09, 2025
Clonal Hematopoiesis of Indeterminate Potential After Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: July 01, 2025
BPI25-014: Pacritinib in Patients With Intermediate-1 Risk Myelofibrosis: Outcomes From Post-Hoc Analysis of Two Phase 3 Studies.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Last Updated: 09/26/2026